Table 1.
Lesion | No. of cases | Versican expression | % of Positive cells | Significance | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Absent | Mild | Moderate | Intense | Significance | 0 | 5% | 6–25% | 26–50% | 51–75% | 76–100% | |||
BMN | 10 | 10 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | ||
DN | 10 | 1 | 3 | 3 | 4 | 0 | 0 | 2 | 4 | 1 | 3 | ||
PMM | 11 | 0 | 1 | 4 | 6 | 0 | 0 | 0 | 1 | 1 | 9 | ||
MMM | 8 | 0 | 2 | 5 | 1 | P < 0.0032 | 0 | 0 | 0 | 0 | 0 | 8 | P < 0.00015 |
BMN, benign melanocytic nevi; DN, dysplastic nevi; PMM, primary malignant melanoma; MMM, metastatic melanoma.